New Zealand markets open in 8 hours 2 minutes

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.73+0.23 (+2.71%)
As of 09:52AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-1.56-5.25-16.94-21.56
Low estimate-4.5-7-20.5-31.25
High estimate1.5-3-11.5-13.75
Year ago EPS-17-16.5-65.25-16.94
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate39.99M17.39M109.9M50.99M
Low estimate16MN/A76.9M16M
High estimate56.6M47.36M149.43M107.53M
Year ago sales3.77M4.76M8.57M109.9M
Sales growth (year/est)960.70%265.30%1,181.90%-53.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-16.81-16.55-12.05-6.41
Actual EPS-17-16.5-14-5.75
Difference-0.190.05-1.950.66
Surprise %-1.10%0.30%-16.20%10.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.56-5.25-16.94-21.56
7 days ago-1.56-5.25-16.94-16.45
30 days ago-0.09-0.18-0.64-0.66
60 days ago-0.14-0.26-0.72-0.46
90 days ago-0.26-0.36-1.06-0.55
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesATRAIndustrySector(s)S&P 500
Current qtr.90.80%N/AN/AN/A
Next qtr.68.20%N/AN/AN/A
Current year74.00%N/AN/AN/A
Next year-27.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A